본문 바로가기 대메뉴 바로가기

진료과 검색

충북대학교병원 로고
게시물 검색
의료진 찾기

[총 0명이 검색되었습니다.]

혈액종양내과

한혜숙 교수

전문분야

위암, 식도암, 대장암, 위장관기질/신경내분비종양, 췌담도암

진료일정

원모양 외래 삼각형모양 클리닉
테이블 자료 : 진료시간, 오전, 오후, 요일별 가능날짜 정보제공
월 화 수 목 금
오전 진료 진료 진료
오후
비고 -
학회 및 출장등의 이유로 실제 진료스케줄과 차이가 있을 수 있습니다.
한혜숙 교수

충북대학교병원 X 혈액종양내과

의료진 한마디

학력 및 경력

  • 충북대학교 의과대학 의학사
  • 충북대학교 의과대학 의학석사
  • 충북대학교 의과대학 의학박사
  • 충북대학교병원 내과 전공의 과정 수료
  • 서울대학교병원 혈액종양내과 전임의
  • 국립암센터 전임의
  • 한국과학기술원(KAIST) 겸직교수
  • 현 충북대학교 의과대학 교수

학회활동

  • 미국임상암학회 정회원
  • 한국호스피스완화의료학회 정회원
  • 대한항암요법연구회 정회원
  • 한국임상암학회 정회원
  • 대한암학회 정회원
  • 대한내과학회 정회원
논문연구실적 - 발표년도, 논문명 정보 제공
발표년도 제목
2022 Optimal Duration of Adjuvant Chemotherapy for GastricCancer: Might Less Be More?. JOURNAL OF GASTRIC CANCER 2022;22(2):79-82 2021 The Prognostic Ability of RAS Pathway-Related GeneMutations in Patients with Myeloid Neoplasms Treatedwith Hypomethylating Agents. ACTA HAEMATOLOGICA 2021;144(6):649-659 2021 Ramucirumab plus paclitaxel as second-line treatment inpatients with advanced gastric or gastroesophagealjunction adenocarcinoma: a nationwide real-worldoutcomes in Korea study (KCSG-ST19-16). THERAPEUTIC ADVANCES IN MEDICALONCOLOGY 2021;13():17,588,359,211,042,812- 2021 E-Cadherin and Angiopoietin-2 as Potential Biomarkersfor Colorectal Cancer With Peritoneal Carcinomatosis. ANTICANCER RESEARCH 2021;41(9):4497-4504 2021 Significance of descriptive symptoms and signs andclinical parameters as predictors of neuropathic cancerpain. PLOS ONE 2021;16(8):e0251781- 2021 Effects of Video Based Information Provision Using aSmart Pad on Patients Undergoing Bone Marrow Biopsy. CLINICAL NURSING RESEARCH 2021;30(6):724-733 2021 Effectiveness of Combining Bevacizumab With First-LineChemotherapy Regimens for Metastatic ColorectalCancer in Real-World Practice. CLINICAL COLORECTAL CANCER 2021;20(2):101-112 2021 ARAF mutations confer resistance to the RAF inhibitorbelvarafenib in melanoma. NATURE 2021;594(7863):418-418 2021 Value Frameworks: Adaptation of Korean Versions ofValue Frameworks for Oncology. INTERNATIONAL JOURNAL OFENVIRONMENTAL RESEARCH AND PUBLICHEALTH 2021;18(6):- 2021 TOX-expressing terminally exhausted tumor-infiltratingCD8 + T cells are reinvigorated by co-blockade of PD-1and TIGIT in bladder cancer. CANCER LETTERS 2021;499():137-147 2021 Comparison of Bleeding, Hematoma, Pain, andDiscomfort After Bone Marrow Examination With orWithout Sandbag Compression. ASIAN NURSING RESEARCH 2021;15(1):150-156 2021 Multicenter phase III trial of S 1 and cisplatin versus S 1and oxaliplatin combination chemotherapy for first linetreatment of advanced gastric cancer (SOPP trial). GASTRIC CANCER 2021;24(1):156-167 2020 Germline JAK2 V617F mutation as a susceptibility genecausing myeloproliferative neoplasm in first-degreerelatives. LEUKEMIA & LYMPHOMA 2020;61(13):3251-3254 2020 Distinct tumor immune microenvironments in primaryand metastatic lesions in gastric cancer patients. SCIENTIFIC REPORTS 2020;10(1):- 2020 Analysis of EGFR mutation status in malignant pleuraleffusion and plasma from patients with advanced lungadenocarcinoma. CLINICAL CHEMISTRY AND LABORATORYMEDICINE 2020;58(9):1547-1555 2020 Analysis of EGFR mutation status in malignant pleuraleffusion and plasma from patients with advanced lungadenocarcinoma. CLINICAL CHEMISTRY AND LABORATORYMEDICINE 2020;58(9):1547-1555 2020 Differences in diagnosis, treatment, and survival rate ofacute myeloid leukemia with or without disabilities: Anational cohort study in the Republic of Korea. CANCER MEDICINE 2020;9(15):5335-5344 2020 Bile-derived circulating extracellular miR-30d-5p andmiR-92a-3p as potential biomarkers forcholangiocarcinoma. HEPATOBILIARY & PANCREATIC DISEASESINTERNATIONAL 2020;19(1):41-50 2019 A phase I/II study of poziotinib combined with paclitaxeland trastuzumab in patients with HER2-positiveadvanced gastric cancer. GASTRIC CANCER 2019;22(6):1206-1214 2019 A Case of Acquired Amegakaryocytic Thrombocytopeniawith Anti-c-mpl Autoantibody: Comparison withIdiopathic Thrombocytopenic Purpura. ACTA HAEMATOLOGICA 2019;142(4):239-243 2019 Discordance in HER2 status between primary gastricadenocarcinoma tumors and cells from thecorresponding malignant effusions. BMC CANCER 2019;19(1):- 2019 Therapeutic Effect of pHLIP-mediated CEACAM6 GeneSilencing in Lung Adenocarcinoma. SCIENTIFIC REPORTS 2019;9():- 2019 Exosomal miR-181b-5p Downregulation in AscitesServes as a Potential Diagnostic Biomarker for GastricCancer-associated Malignant Ascites. JOURNAL OF GASTRIC CANCER 2019;19(3):301-314 2019 Quality of life outcomes includingneuropathy-associated scale from a phase II,multicenter, randomized trial of eribulin plusgemcitabine versus paclitaxel plus gemcitabine asfirst-line chemotherapy for HER2-negative metastaticbreast cancer: Korean Cancer Study Group Trial (KCSGBR13-11). CANCER COMMUNICATIONS 2019;39(1):29- 2019 A Randomized, Double-Blind, Placebo-Controlled Studyof the Safety and Efficacy of Olanzapine for thePrevention of Chemotherapy-Induced Nausea andVomiting in Patients Receiving Moderately EmetogenicChemotherapy: Results of the Korean South WestOncology Group (KSWOG) Study. CANCER RESEARCH AND TREATMENT 2019;51(1):90-97 2018 A phase II trial of the pan-HER inhibitor poziotinib, inpatients with HER2-positive metastatic breast cancerwho had received at least two prior HER2-directedregimens: results of the NOV120101-203 trial. INTERNATIONAL JOURNAL OF CANCER 2018;143(12):3240-3247 2018 Feasibility and accessibility of electronic patient-reportedoutcome measures using a smartphone during routinechemotherapy: a pilot study. SUPPORTIVE CARE IN CANCER 2018;26(11):3721-3728 2018 Long-term Survival after Repeated Local Therapy andSalvage Chemotherapy for Recurrent Metastases fromGastric Cancer: a Case Report and Literature Review. JOURNAL OF GASTRIC CANCER 2018;18(3):305-312 2018 Efficacy and tolerability of ramucirumab monotherapy orin combination with paclitaxel in gastric cancer patientsfrom the Expanded Access Program Cohort by theKorean Cancer Study Group (KCSG). GASTRIC CANCER 2018;21(5):819-830 2018 Diagnostic benefits of the combined use of liquid-basedcytology, cell block, and carcinoembryonic antigenimmunocytochemistry in malignant pleural effusion. JOURNAL OF THORACIC DISEASE 2018;10(8):4931-4939 2018 EGFR Mutation Status in LungAdenocarcinoma-Associated Malignant Pleural Effusionand Efficacy of EGFR Tyrosine Kinase Inhibitors. CANCER RESEARCH AND TREATMENT 2018;50(3):908-916 2018 Prevalence of and factors associated with anxiety anddepression in Korean patients with newly diagnosedadvanced gastrointestinal cancer. KOREAN JOURNAL OF INTERNALMEDICINE 2018;33(3):585-594 2018 Sequential spinal and intracranial dural metastases ingastric adenocarcinoma: A case report. WORLD JOURNAL OFGASTROENTEROLOGY 2018;24(5):651-656 2018 Long-term survival after gastrectomy andmetastasectomy for gastric cancer with synchronousbone metastasis. WORLD JOURNAL OFGASTROENTEROLOGY 2018;24(1):150-156 2017 Multicenter, cross-sectional observational study of theimpact of neuropathic pain on quality of life in cancerpatients. SUPPORTIVE CARE IN CANCER 2017;25(12):3759-3767 2017 Clinical features of gastric emptying after distalgastrectomy. ANNALS OF SURGICAL TREATMENT ANDRESEARCH 2017;93(6):310-315 2017 Comparison of efficacy and tolerance betweencombination therapy and monotherapy as first-linechemotherapy in elderly patients with advanced gastriccancer: Study protocol for a randomized controlled trial. Contemporary Clinical TrialsCommunications 2017;8():55-61 2017 Phase II, multicentre, randomised trial of eribulin plusgemcitabine versus paclitaxel plus gemcitabine asfirst-line chemotherapy in patients with HER2-negativemetastatic breast cancer. EUROPEAN JOURNAL OF CANCER 2017;86():385-393 2017 A Multicenter Randomized Phase II Study of Docetaxelvs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 asSecond-Line Chemotherapy in Metastatic Gastric CancerPatients Who Had Progressed after Cisplatin Plus EitherS-1 or Capecitabine. CANCER RESEARCH AND TREATMENT 2017;49(3):706-716 2017 A Case of Pulmonary Langerhans Cell SarcomaSimultaneously Diagnosed with Cutaneous LangerhansCell Histiocytosis Studied by Whole-Exome Sequencing. ACTA HAEMATOLOGICA 2017;138(1):24-30 2017 Efficacy and Safety of FOLFIRI Regimen in Elderly VersusNonelderly Patients with Metastatic Colorectal or GastricCancer. ONCOLOGIST 2017;22(3):293-303
번호, 진료언론사, 보도명, 보도일자 정보제공
번호 언론사 보도명 보도일자